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INTRODUCTION 
Guillain-Barre syndrome (GBS) annually affects one to 
four per 100,000 of the population globally, [1] 
approximately 38.50% [2] requiring ventilator support 
resulted from respiratory failure. Death in 4.11% [2] 
persistent disability in 20% [3] of population, and 
persistent fatigue in 67%.[3] Guillain-Barre Syndrome is 
a rare but serious autoimmune disorder in which 
immune system attacks healthy nerve cells of 
peripheral nervous system. This lead to weakness, 
numbness and tingling that eventually leads to 
paraparesis or paralysis. GBS is classified into 
demyelinating and axonal form on a basis of pathology. 
Axonal GBS has been further classified into acute 
motor axonal neuropathy (AMAN) and acute motor and 
sensory axonal neuropathy 
(AMSAN).[4,5] The Principal clinical method for 
distinguishing AMAN, AMSAN and acute inflammatory 
demyelinating polyneuropathy (AIDP) is electro 
diagnostic, and clear criteria have been formulated. The 
pathology of AMAN and AMSAN is very similar, and both 
conditions may preceded by enteritis caused by 
Campylobacter jejuni. [6] Standard protocol of nerve 
conduction studies was followed and patients were 
classified as having AMAN or AIDP based on the electro 
diagnostic criteria proposed by Hughes and Cornblath 
recently; i.e. none of the features of AIDP [5] except one 
demyelinating feature allowed in one nerve if distal 
compound muscle action potential is less than 10% of 
lower limit of normal and Sensory action potential 
amplitudes are normal. Blood cell counts and routine 
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ABSTRACT 
BACKGROUND: Guillain-Barre syndrome (GBS) is a post-infectious, immune-mediated disease that causes a rapidly 
progressing poly-radiculoneuropathy resulting in weakness and areflexia. It has several variant forms like AIDP, AMAN 
and AMSAN.
Objective: To determine frequency of finger drop sign in AMAN and AIDP variant of GBS; a diagnostic factor of AMAN 
variant.
Material and Methods: A Cross sectional study conducted at neurology department of Pakistan Institute of Medical 
Sciences. After meeting the inclusion criteria 96 patients were enrolled. Clinical assessment was done i.e. power of 
the patient was checked and recorded according to the MRC sum score, finger drop sign was checked at time of 
presentation and NCS was done and variant of GBS noted. The data thus collected was entered on a standardized 
Performa.
Results: The mean age of the patients was 42.04±18.97 years, 66(68.75%) patients were males. At presentation 
the mean MRC sum score of the patients was 33.91±9.86 while at discharge the mean MRC sum score of the 
patients was 45.27±13.36. AMAN variant of GBS was noted in 35(36.46%) patients and AIDP variant of GBS was 
noted in 61(63.54%) patients. Comparison of finger drop with variant of GBS showed significant difference 
(p-value<0.05).
Conclusion: According to this study approximately one third of the patients had AMAN variant and two third of the 
patients had AIDP variant of GBS. In AMAN variant the finger drop noted in all patients.
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blood chemistry tests were done at the first 
neurological examination, cerebrospinal fluid analysis 
was done to look for cytoalbuminologic dissociation, 
which is also a supportive evidence of GBS. AMAN 
variant of GBS shows characteristic pattern of severe 
distal weakness with varying degree of proximal 
weakness. This pattern consisted of severe finger 
extensor weakness (i.e. at the metacarpophalangeal 
and interphalangeal Joints) in the presence of relatively 
normal power in finger flexion, wrist flexion and wrist 
extension-the "finger drop sign”. [3] AMAN is distinct 
subgroup in GBS showing certain distinguishing 
features, most notable being predominant weakness of 
finger extensor. Among 84 cases of all variant of GBS 
AMAN represent 14.2% [3] of cases and AIDP 78.5% [3] 
of cases. All of the patients presented with weakness in 
upper and lower limbs, but one of the distinguishing 
feature between AMAN and AIDP variant was finger 
drop sign that was seen in 100% of AMAN variant 
patients and none of AIDP variant had finger drop sign. 
Hence, the purpose of this study is to assess the 
frequency of finger drop sign in GBS patients with both 
variants i.e. AMAN and AIDP variant that will help us to 
identify the variant of GBS on clinical examination.
MATERIAL AND METHODS:
A Cross sectional study conducted at neurology 
department of Pakistan Institute of Medical Sciences 
after approval from ethical committee. After meeting 
the inclusion criteria 96 patients were enrolled in a 
period of 2 years from 2018 to 2020. After informed 
consent, all patients diagnosed as Guillain-Barre 
syndrome based on the clinical criteria were inquired 
about history, neurological examination was done and 
nerve conduction studies were performed.  Clinical, 
NCS finding record included: power of the patient via 
MRC sum score in AMAN and AIDP variant of GBS, 
finger drop sign at the time of presentation and 
abnormality in NCS. Demographic features recorded, 
include aged and gender. Data was analyzed using 
SPSS version 23. Frequencies and percentages were 
calculated for Qualitative variables (gender, preceding 
infection, 7th cranial nerve palsy, power of muscles 
(Deltoid, Biceps, Muscles causing wrist extension 
(including extensor carpi radialis longus (ECRL), 
extensor carpi radialis brevis (ECRB), extensor 
digitorum (ED), extensor digiti minimi (EDM), extensor 
carpi ulnaris (ECU),  extensor indices (EI)), Iliopsoas, 
Quadriceps, Tibialis anterior) recorded as MRC sum 
score in AMAN and AIDP variant and finger drop sign. 
While Mean and Standard deviations were calculated 
for age. Statistical Significance was indicated by 
p-value < 0.05 using Chi Square test for comparison of 
finger drop sign between AMAN and AIDP variant.
RESULTS:
In our study total 96 patients were enrolled. The mean 
age of the patients was 42.04±18.97 years with 
minimum age of 15 & maximum age of 83 years (Table 
1). In this study 66(68.75%) patients were male while 
30(31.25%) patients were females. Male to female 
ratio of the patients was 2.2:1. (Fig 1). At presentation 
the mean MRC sum score of the patients was 
33.91±9.86 while at discharge the mean MRC sum 
score of the patients was 45.27±13.36. (Table 2). 
According to this study AMAN variant of GBS was noted 
in 35(36.46%) patients and AIDP variant of GBS was 
noted in 61(63.54%) patients (Fig 2). In our study the 
cranial nerve palsy was noted in 6(6.3%) patients. 
(Table 3). In our study the finger drop was found in 
35(36.46%) patients (Fig 3). In this study in deltoid, 
the mean MRC grade of AMAN variant was 2.81±0.91 
while the mean MRC grade of AIDP variant of GBS was 
3.99±0.81. In biceps, the mean MRC grade of AMAN 
variant was 2.90±0.86 while the mean MRC grade of 
AIDP variant of GBS was 4.00±0.86. In wrist, the 
mean MRC grade of AMAN variant was 2.59±0.81 
while the mean MRC grade of AIDP variant of GBS was 
4.53±0.32. In iliopsoas, the mean MRC grade of 
AMAN variant was 2.62±3.84 while the mean MRC 
grade of AIDP variant of GBS was 3.84±0.97. In 
quadriceps, the mean MRC grade of AMAN variant was 
2.77±0.95 while the mean MRC grade of AIDP variant 
of GBS was 3.96±0.87. In Tibialis anterior the mean 
MRC grade of AMAN variant was 2.86±0.91 while the 
mean MRC grade of AIDP variant of GBS was 
4.02±0.94. (Table 4). The study results showed that in 
GBS variant AMAN the finger drop was found in 
35(100%) patients whereas in GBS variant AIDP the 
finger drop was not found in even a single patient (fig. 
4). This difference was statistically significant. I.e. 
p-value<0.05. (Table 5)
This study showed that among GBS variant AMAN the 
cranial nerve palsy was observed in 1(2.9%) patients 
whereas among GBS variant AIDP the cranial nerve 
palsy was observed in 5(8.2%) patients. This difference 
was statistically insignificant. I.e. p-value>0.411. 
(Table 6)
Table 1
Summary statistics of age (years)
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Fig 1
Frequency distribution of gender
Table 2
Summary statistics of MRC grade at presentation and 
at discharge
Fig 2
Frequency distribution of GBS findings
Table 3
Frequency distribution of 7th cranial nerve palsy
Fig 3
Frequency distribution of finger drop sign 
Fig 4
Frequency of finger drop sign in AIDP and AMAN variant
Table 4
Summary statistics of AMAN & AIDP variant of GBS
Table 5
Comparison of finger drop and GBS variant
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Table 6
Comparison of GBS variant with cranial nerve palsy
DISCUSSION:
GBS is the most common cause of acute or 
sub-acute generalized paralysis in clinical practice. 
The Guillain-Barre syndrome (GBS) is a disease of the 
peripheral nervous system that is characterized by 
segmental demyelination and infiltration of 
mononuclear cells in peripheral nerves, nerve roots 
and deposition of complement with axonal 
degeneration in severe lesions.[7]  The subtypes of 
GBS have different incidence rates in different parts 
of the world. In Europe and North America AIDP is 
dominant contributing to 90% of the cases. In 
contrast in China and Japan AMAN being the most 
common subtype. [8] This present cross sectional 
study was carried out at department of Neurology, 
PIMS, Islamabad to determine frequency of AMAN 
and AIDP variant of GBS and to determine frequency 
of finger drop sign among AMAN and AIDP variant of 
GBS The picture is intermediate when we look at 
other population. In Indian series the incidence of 
AIDP and AMAN are virtually equal although AMAN is 
more common in younger patients. There seems to be 
a slight preponderance of AIDP in studies by Gupta et 
al [9] and by Meena et al (unpublished data from 
NIMS, Hyderabad).[9] In this study AMAN variant of 
GBS was noted in 35(36.46%) patients and AIDP 
variant of GBS was noted in 61(63.54%) patients. 
The finger drop was found in 35(36.46%) patients. 
GBS includes many subtypes such as AIDP, AMAN, 
FS, Bickerstaff’s brain stem encephalitis-GBS, etc. 
AIDP and AMAN was referred frequently in the 
previous reports [10-12]. Report from northern China 
suggest that AMAN accounts for approximately 65% 
of patients with GBS [13]. In another study, Ye Y, et al 
reported that AMAN accounts for 33% in northeast 
China. [12] Muhammad Babar Khan et al [14] done a 
study on frequency of axonal variants of Guillain-Barre 
syndrome in Pakistan. The author resulted that 
variants of Guillain-Barre Syndrome were AIDP in 
24(60%) patients followed by AMAN in 12(30%) and 
AMSAN in 4(10%) patients. Islam et al [15] and 
Shafqat et al [16] show that in our region the axonal 
variants of GBS are common. Most experience with 
the generalized axonal forms of GBS, AMAN and 
AMSAN, indicates that recovery is prolonged, 
complete resolution of weakness is uncommon and 
response to conventional therapy is not very 
encouraging [17]. As a group, patients with AMAN have 
a more rapid progression of weakness to an earlier 
nadir than in AIDP resulting in prolonged paralysis and 
respiratory failure over a few days. [17] According to this 
study the in GBS variant AMAN the finger drop was 
found in 35(100%) patients whereas in GBS variant 
AIDP the finger drop was not found in even a single 
patient (p-value<0.05). This study showed that 
among GBS variant AMAN the cranial nerve palsy was 
observed in 1(2.9%) patients whereas among GBS 
variant AIDP the cranial nerve palsy was observed in 
5(8.2%) patients. This difference was statistically 
insignificant. I.e. p-value>0.411 Arun George et al 
[3] presented in their study that there were 12 cases 
of AMAN out of a total of 84 cases of GBS. All AMAN 
patients showed a characteristic pattern of hand 
weakness predominant weakness of finger extensors 
with relatively normal power in finger flexors, wrist 
flexors and extensors. Proximal limb weakness was 
mild and was present in 85% cases. Among 84 cases 
of all variant of GBS AMAN represent 14.2% [3] of 
cases and AIDP 78.5% [3] of cases. 100% of AMAN 
variant showed finger drop sign and none of AIDP 
variant has finger drop sign. Studies showed that 
Patients with AMAN were considered to have greater 
long-term disability [18] whereas patients with AIDP 
were generally at high risk for rapid deterioration and 
need of mechanical ventilation. [19]
CONCLUSION:
According to this study approximately one third of the 
patients had AMAN variant and two third of the 
patients had AIDP variant of GBS. Finger drop is 
peculiar sign, noted in all patients presented with 
AMAN variant of GBS.
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